Granules India rose 1.57% to Rs 326.90 after the company said that US drug regulator has approved its Abbreviated New Drug Application (ANDA) for Acetaminophen, Aspirin and Caffeine Tablets USP, 250 mg/250 mg/65 mg (OTC).The product is bioequivalent to the reference listed drug product (RLD), Excedrin migraine tablets, 250 mg/250 mg/65 mg, of GlaxoSmithKline Consumer Healthcare.
The drug is indicated for treating migraine. The product will be manufactured at the company s Hyderabad facility and is expected to be launched shortly.
Priyanka Chigurupati, Executive Director, Granules Pharmaceuticals, Inc., commenting on the approval, said: We are pleased to announce approval of acetaminophen, aspirin and caffeine tablets, emphasizing our focus on building sustainable OTC product portfolio in the US market. We received approval for this triple combination product within 14 months from filing. With this, we have received three ANDA approvals over the past month.
Granules India announced today that the US Food & Drug Administration (US FDA) has approved its
Abbreviated New Drug Application (ANDA) for Acetaminophen, Aspirin and Caffeine Tablets USP, 250
mg/250 mg/65 mg (OTC).
It is bioequivalent to the reference listed drug product (RLD), Excedrin Migraine
Tablets, 250 mg/250 mg/65 mg, of GlaxoSmithKline Consumer Healthcare. The product would be
manufactured at the company s Hyderabad facility and is expected to be launched shortly.
Acetaminophen, Aspirin and Caffeine Tablets are indicated for the treatment of migraine.
Granules now has a total of 38 ANDA approvals from US FDA (37 Final approvals and 1 tentative
approval)
Powered by Capital Market - Live News
HFCL Limited, one of the top two India s optic fibre makers, is planning to increase Fibre-to-the-Home or FTTH cable production by 33% at its Hyderabad facility following the robust domestic and overseas demand, and a Rs 7,500-crore order book.
HFCL starts commercial production of FTTH Cables from new Facility in Hyderabad
Posted On: 2020-12-17 00:49:59 (Time Zone: Arizona, USA)
HFCL s new Fiber-to-the-home (FTTH) Cable manufacturing Facility at Hyderabad, Telangana has commenced commercial production of Optical Fiber Cables for Fiber to Home Applications, w.e.f. 16th December, 2020. With the start of this new Facility at Hyderabad, HFCL together with its subsidiary company, viz. HTL Limited, has become the largest manufacturer of FTTH cables in India with a capacity of 6 lakh kms per annum.
The Company had earlier invested Rs.260 crores in Hyderabad Plant for the manufacturing of Optical Fiber that was commissioned in January, 2020. This new state-of-the-art, automated high-speed FTTH cable Facility has come up with a fresh outlay of Rs.40 crores to ensure high throughput, economies of scale and highest quality standards. Thus far, Rs.300 crores have been invested in Hyderabad Facility as part of the Company s ex